Skip to main content

Advertisement

SpringerLink
Log in

DCE MRI of prostate cancer

  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

DCE MRI is an established component of multi-parametric MRI of the prostate. The sequence highlights the vascularization of cancerous lesions, allowing readers to corroborate suspicious findings on T2W and DW MRI and to note subtle lesions not visible on the other sequences. In this article, we review the technical aspects, methods of evaluation, limitations, and future perspectives of DCE MRI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Humphrey PA (2014) Cancers of the male reproductive organs. In: Stewart BW, Wild CP (eds) World cancer report. Lyon: World Health Organization

    Google Scholar 

  2. Delongchamps NB, Singh A, Haas GP (2006) The role of prevalence in the diagnosis of prostate cancer. Cancer Control 13(3):158–168

    PubMed  Google Scholar 

  3. Ries LAG, Melbert D, Krapcho M, et al. (eds) (1975–2004) SEER cancer statistics review, National Cancer Institute, Bethesda, MD 2007. Available on http://seer.cancer.gov/csr/1975_2004/

  4. Fütterer JJ, Briganti A, De Visschere P, et al. (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. 68(6):1045–1053

    Article  PubMed  Google Scholar 

  5. Guo R, Cai L, Fan Y, et al. (2015) Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis. Prostate Cancer Prostatic Dis. doi:10.1038/PCan.2015.20

    Google Scholar 

  6. Hoeks CM, Barentsz JO, Hambrock T, et al. (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66

    Article  PubMed  Google Scholar 

  7. Qayyum A, Coakley FV, Lu Y, et al. (2004) Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. Am J Roentgenol 183(4):1079–1083

    Article  Google Scholar 

  8. Hedgire SS, Eberhardt SC, Borczuk R, McDermott S, Harisinghani MG (2014) Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices. Abdom Imaging. 39(5):1036–1051

    Article  PubMed  Google Scholar 

  9. Alonzi R, Padhani AR, Allen C (2007) Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 63:335–350

    Article  PubMed  Google Scholar 

  10. Tan CH, Wang J, Kundra V (2011) Diffusion weighted imaging in prostate cancer. Eur Radiol 21:593–603

    Article  PubMed  Google Scholar 

  11. Verma S, Turkbey B, Muradyan N, et al. (2012) Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. Am J Roentgenol 198(6):1277–1288

    Article  Google Scholar 

  12. Bonekamp D, Macura KJ (2008) Dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the prostate. Top Magn Reson Imaging 19(6):273–284

    Article  PubMed  Google Scholar 

  13. Turkbey B, Mena E, Aras O, et al. (2013) Functional and molecular imaging: applications for diagnosis and staging of localised prostate cancer. Clin Oncol 25(8):451–460

    Article  CAS  Google Scholar 

  14. Wegiel B, Bjartell A, Ekberg J, et al. (2005) A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer. Oncogene 24:6385–6393

    CAS  PubMed  Google Scholar 

  15. Green MM, Hiley CT, Shanks JH, et al. (2007) Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome. Int J Radiat Oncol Biol Phys 67:84–90

    Article  CAS  PubMed  Google Scholar 

  16. Mucci LA, Powolny A, Giovannucci E, et al. (2009) Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J Clin Oncol 27:5627–5633

    Article  PubMed  PubMed Central  Google Scholar 

  17. Erbersdobler A, Isbarn H, Dix K, et al. (2010) Prognostic value of microvessel density in prostate cancer: a tissue microarray study. World J Urol 28:687–692

    Article  PubMed  Google Scholar 

  18. Mucci LA, Powolny A, Giovannucci E, et al. (2009) Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the Health Professionals Follow-Up Study. J Clin Oncol 27:5627–5633

    Article  PubMed  PubMed Central  Google Scholar 

  19. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186

    Article  CAS  PubMed  Google Scholar 

  20. de Bazelaire CM, Duhamel GD, Rofsky NM (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230(3):652–659

    Article  PubMed  Google Scholar 

  21. Sertdemir M, Schoenberg SO, Sourbron S (2013) Interscanner comparison of dynamic contrast-enhanced MRI in prostate cancer: 1.5 versus 3 T MRI. Invest Radiol 48(2):92–97

    Article  PubMed  Google Scholar 

  22. Muller BG, Kaushal A, Sankineni S, et al. (2015) Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy. Urol Oncol 33(10):425.e1–425.e6

    Article  Google Scholar 

  23. American College of Radiology (2015) MR prostate imaging reporting and data system version 2.0. http://www.acr.org/Quality-Safety/Resources/PIRADS/. Accessed 7 2015

  24. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. (2003) Discrimination of prostate cancer form normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229:248–254

    Article  PubMed  Google Scholar 

  25. Girouin N, Mege-Lechevallier F, Tonina Senes A, et al. (2007) Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 17(6):1498–1509

    Article  PubMed  Google Scholar 

  26. Nicholson B, Schaeffer G, Theodorescu D (2001) Angiogenesis in prostate cancer: biology and therapeutic opportunities. Cancer Metastasis Rev 20:297–319

    Article  CAS  PubMed  Google Scholar 

  27. Bigler SA, Deering RE, Brawer MK (1993) Comparison of microscopic vascularity in benign and malignant prostate tissue. Human Pathol 24:220–226

    Article  CAS  Google Scholar 

  28. Siegal JA, Yu E, Brawer MK (1995) Topography of neovascularity in human prostate carcinoma. Cancer 75:2545–2551

    Article  CAS  PubMed  Google Scholar 

  29. Oto A, Kayhan A, Jiang Y, et al. (2010) Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 257(3):715–723

    Article  PubMed  Google Scholar 

  30. Hansford BG, Peng Y, Jiang Y, et al. (2015) Dynamic contrast-enhanced MR imaging curve-type analysis: is it helpful in the differentiation of prostate cancer from healthy peripheral zone? Radiology 275(2):448–457

    Article  PubMed  Google Scholar 

  31. Noworoslski SM, Henry RG, Vigneron DB, et al. (2005) Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI and 3D MRSI. Magn Reson Med 53:249–255

    Article  Google Scholar 

  32. Bonekamp D, Jacobs MA, El-Khouli R, et al. (2011) Advancements in MR imaging of the prostate; from diagnosis to interventions. RadioGraphics 31(3):677–703

    Article  PubMed  PubMed Central  Google Scholar 

  33. Barentz JO, Richenberg J, Clements R, et al. (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22(4):746–757

    Article  Google Scholar 

  34. Tofts PS, Brix G, Buckley DL, et al. (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 10(3):2223–2232

    Article  Google Scholar 

  35. Van Dorsten FA, van der Graaf M, Engelbrecht MR, et al. (2004) Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 20:279–287

    Article  PubMed  Google Scholar 

  36. Knopp MV, Giesel FL, Marecos H, et al. (2001) Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging 12:301–308

    Article  CAS  PubMed  Google Scholar 

  37. Futteter JJ, Engelbrecht MR, Huisman HJ, et al. (2005) Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237:541–549

    Article  Google Scholar 

  38. Ocak L, Bernardo M, Metzger G, et al. (2007) Dynamic contrast-enhanced MRI of prostate cancer a 3T: a study of pharmacokinetic parameters. AJR 189(849):W192–W201

    Article  Google Scholar 

  39. Isebart S, DeKeyzer F, Haustermans K, et al. (2012) Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer correlation to whole-mount histopathology. Eur J Radiol 81:e217–e222

    Article  Google Scholar 

  40. Rosenkrantz AB, Sabach A, Babb JS, et al. (2013) Prostate Cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor. AJR 3:W471–W478

    Article  Google Scholar 

  41. Turkbey B, Pinto PA, Mani H, et al. (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation. Radiology 255:89–99

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hansford BG, Karademir I, Peng Y, et al. (2014) Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate. Acad Radiol 21(5):569–577

    Article  PubMed  Google Scholar 

  43. Tan CH, Hobbs BP, Wei W, Kundra V (2015) Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. Am J Roentgenol 204:W439–W448

    Article  Google Scholar 

  44. Muller BG, van den Bos W, Brausi M, et al. (2015) Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project. World J. Urol. Available on http://www.ncbi.nlm.nih.gov/pubmed/25559111. Accessed 6 Jan 2015

  45. Cha D, Kim CK, Park SY, Park JJ, Park BK (2014) Evaluation of suspected soft tissue lesion in the prostate bed after radical prostatectomy using 3T multiparametric magnetic resonance imaging. Magn Reson Imaging 33(4):407–412

    Article  PubMed  Google Scholar 

  46. Roy C, Foudi F, Charton J, et al. (2013) Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. Am J Roentgenol 200(4):W361–W368

    Article  Google Scholar 

  47. Sciarra A, Panebianco V, Salciccia S, et al. (2008) Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 54(3):589–600

    Article  PubMed  Google Scholar 

  48. Cirillo S, Petracchini M, Scotti L, et al. (2009) Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 19(3):761–769

    Article  PubMed  Google Scholar 

  49. Barrett T, Davidson S (2014) Enhanced MRI as a predictor of vascular-targeted photodynamic focal ablation therapy outcome in prostate cancer post-failed external beam radiation therapy. Can Urol 8:708–714

    Google Scholar 

  50. Low RN, Fuller DB, Muradyan N (2011) Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy. Am J Roentgenol 197(4):907–915

    Article  Google Scholar 

  51. Vos EK, Litjens GJS, Kobus T, et al. (2013) Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T. Eur Urol 64(3):448–455

    Article  PubMed  Google Scholar 

  52. Moradi M, Salcudean SE, Chang SD, et al. (2012) Multiparametric MRI maps for detection and grading of dominant prostate tumors. J Magn Reson Imaging 35(6):1403–1413

    Article  PubMed  Google Scholar 

  53. Turkbey B, Pinto P, Mani H, et al. (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologifc correlation. Radiology 255(1):89–99

    Article  PubMed  PubMed Central  Google Scholar 

  54. Franiel T, Lüdemann L, Rudolph B, et al. (2008) Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared. Investig Radiol 43(7):481–487

    Article  Google Scholar 

  55. Aydin H, Hekimogl B, Tatar IG (2013) Limitations, disabilities, and pitfalls of dynamic contrast-enhanced MRI as a diagnostic modality in prostate cancer. Am J Roentgenol 200(3):W326

    Article  Google Scholar 

  56. Lim C, Quon J, McInnes M, et al. (2015) Does a cleansing enema improve image quality of 3T surface coil multiparametric prostate MRI? J Magn Reson Imaging 42(3):689–697

    Article  PubMed  Google Scholar 

  57. McDonald RJ, McDonald JS, Kallmes DF, et al. (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275(3):772–782

    Article  PubMed  Google Scholar 

  58. Niaf E, Lartizien C, Bratan F, et al. (2014) Prostate focal peripheral zone lesions: characterization at multiparametric MR imaging-influence of a computer-aided diagnosis system. Radiology 271(3):761–769

    Article  PubMed  Google Scholar 

  59. Scheenen TWJ, Rosenkrantz AB, Haider MA, Fütterer JJ (2015) Multiparametric magnetic resonance imaging in prostate cancer management: current status and future perspectives. Investig Radiol . doi:10.1097/RLI.0000000000000163

    Google Scholar 

  60. Wang S, Burtt K, Turkbey B, Choyke P, Summers RM (2014) Computer aided-diagnosis of prostate cancer on multiparametric MRI: a technical review of current research. BioMed Res Int 2014:789561

    PubMed  PubMed Central  Google Scholar 

  61. Kwak JT, Xu S, Wood BJ, et al. (2015) Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imaging. Med Phys 42(5):2368–2378

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182 Bldg 10, Room B3B85, Bethesda, MD, 20892-1088, USA

      Rose M. Berman, Anna M. Brown, Sandeep Sankineni, Peter L. Choyke & Baris Turkbey

    2. Duke University School of Medicine, Durham, NC, USA

      Anna M. Brown

    3. Department of Radiology, University of British Columbia, Vancouver, BC, Canada

      Silvia D. Chang

    4. Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

      Meet Kadakia & Peter A. Pinto

    5. Diagnostic Radiology Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD, USA

      Bradford J. Wood

    Authors
    1. Rose M. Berman
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Anna M. Brown
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Silvia D. Chang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Sandeep Sankineni
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Meet Kadakia
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Bradford J. Wood
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Peter A. Pinto
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Peter L. Choyke
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Baris Turkbey
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Baris Turkbey.

    Additional information

    Rose M. Berman and Anna M. Brown have contributed equally for this manuscript.

    Electronic supplementary material

    Below is the link to the electronic supplementary material.

    Supplementary material 1 (AVI 28387 kb)

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Berman, R.M., Brown, A.M., Chang, S.D. et al. DCE MRI of prostate cancer. Abdom Radiol 41, 844–853 (2016). https://doi.org/10.1007/s00261-015-0589-3

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00261-015-0589-3

    Keywords

    Search

    Navigation